Claudin-7 regulates EpCAM-Mediated functions in tumor progression

Molecular Cancer Research

Volumn 7, Issue 3, 2009, Pages 285-299

  Nübel, Tobias ^a   Preobraschenski, Julia ^a   Tuncay, Hüseyin ^a   Weiss, Tobias ^a   Kuhn, Sebastian ^a   Ladwein, Markus ^a,d   Langbein, Lutz ^a   Zöller, Margot ^a,b,c,e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Steinhoevelstrasse 2 D 89075 U   (Germany)

^c UNIVERSITY OF KARLSRUHE   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CLAUDIN 7; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELL ADHESION MOLECULE; TETRASPANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASCITES; CANCER GROWTH; CARCINOGENICITY; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN HEK293; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; THYMUS; TIGHT JUNCTION;

ADENOCARCINOMA; ANIMALS; ANTIGENS, NEOPLASM; CELL ADHESION; CELL ADHESION MOLECULES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RATS; TRANSFECTION;

RATTUS;

EID: 62549135313     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0200     Document Type: Article

References (60)

1. r 34,000 human epithelium specific surface glycoprotein in normal and malignant tissues, Cancer Res 1987;47:2883-91.
2. Bergsagel PL, Victor-Kobrin C, Brents LA, et al. Genes expressed selectisely in plasmacytomas: markers of differentiation and transformation. Curr Top Microbiol Immunol 992: 82:22-8.
3. Balzar M, Winter MJ, de Boer CJ,Litsinos sv. The biology of the 17-1A antigen (Ep CAM). .1 Mol Med 1999;77:699-712.
4. Gastl G, Spizzo G, Obrist P. Dunser M, Mikuz G. Ep CAM overexpression in breast cancer as a predictor of survival. Lancet 2000;356:1981-2.
5. Braun 9, Pantel K. Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 1998;52:201-16.
6. Litsinos SV, van Driel W, van Rhijn CM, et al. Expression of Ep CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol t996;148: 865-75.
7. Ruck PP, Wichert G, Handgretinger R, Kaiserling C Ep-CAM in malignant liver tumours. J Pathol 2000;19t:102-3.
8. Seligson DB, Pantuck AJ, Liu X. et al. Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 2004;10:2659-69.
9. Went PT, Lugli A, Meier S, et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004;35:122-8.
10. Basak S, Speicher D, Eck S, et al Colorectal carcinoma insasion inhibition by CD17-1A/GA733 antigen and its murine homologue. J Nat1 Cancer Inst 1998; 90:691-7.
11. Herlyn M, Steplessski Z, Herlyn D, Koprowski H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc NatI Acad Sci U S A 1979;76:1438-42.
12. Fleuren GJ, Gorter A, Kuppen PJ, Litvinov S. Warnaar SO. Tumor heterogeneity and immunotherapy of cancer. Immunol Res 1995;145:91-122.
13. Piyathilake CJ. Frost AR. Weiss H, Manne U, Heimburger DC, Grizzle WE. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol 2000;31:482-7.
14. Kuhn S, Koch M, Nübel T, et al. A complex of EpCAM. claudin 7. CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 2007;5:555-67.
15. Ponti H, Zaffaroni N, Capelli C, et al. Breast cancer stem cells: an oserview. Eur J Cancer 2006;42:1219 24.
16. O'Brien CA, Pollett A, Gallinger S, et al A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445: 106-10.
17. Ricci-Vitiani C, Lombardi DG, Pilozzi E. et al. Identification arid expansion of human colon cancer-initiating cells. Nature 2007;445:111-5.
18. Dalerba P. DyIla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Nat1 Acad Sci U S A 2007;104:10158-63.
19. Li C, Heidt DG, Dalerba P. et al. Identification of pancreatic cancer stem cells. Cancer Res 2007:67:1030-7.
20. Chong JM, Speicher DW. Determination of disulfide bond assignments and N glycosylation sites of the human gastrointestinal carcinoma antigen 6A733-2 (C017-lA, COP, KS1-4, KSA, and Ep-CAM). J Biol Chem 2001;276:5804-13.
21. Tiabak M, Begg GE, Chong JM, et al. Oligomeric state of the colon carcinoma associated glycoprotein GA733 2 (Ep CAM EGP40) and its role in GA733-mediated homotypic cell cell adhesion. .J Biol Chem 2001 ;276:2299-309.
22. Balzar M, Briaire de Bruijn IR, Rees-Bakker HA, et al, Epidermal growth factor like repeats mediate lateral and reciprocal interactions of Ep CAM molecules in homophitic adhesions. Mol Cell Biol 2001:21:2570-80.
23. Behrens J. Cell contacts, differentiation, and invasiseness of epitheliat cells, Insasion Metastasis 1994;14:61-70.
24. Winter MJ, Nagelkerken B, Mertens AC, et al, Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak, Exp Cell Res 2003;285:50-8.
25. Hashida H, Takabayashi A, Tokusara T, et al, Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer 2003;89:158-67.
26. Mayer B, Klement G, Kaneko M, et al, Multicellular gastric cancer spheroids recapitulate growth pattern arid differentiation phenotype of human gastric carcinomas, Gastroenterology 2001; 121:839-52,
27. Guillemot JC, Naspetti M, Malergue F, et al. Ep-CAM transfection in thymic epithelial cell lines triggers the formation of dynamic actin-rich protrusions involved in the organization of epithelial cell layers. Histochem Cell Biol 2001; 116:371-8.
28. Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004; 64:5818-24.
29. Hussain S, Pluckthun A, Allen TM, et al. Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL. Mol Cancer Ther 2006;5:3170-80.
30. Münz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM up-regulates c-myc and induces cell proliferation. Oncogene 2004;23:5748-58.
31. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007;96:417-23.
32. Würfel J, Rösel M, Seiter S, et al. Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314. Oncogene 1999;18:2323-34.
33. Schmidt DS, Schnölzer M, Klingbeil P, Zöller M. CD44 variant isoforms associate with tetraspanins and selectively with EpCAM: consequences on cell cell and cell matrix adhesion. Exp Cell Res 2004;297:329-47.
34. Ladwein M, Schmidt DS, Schnölzer M, et al. The cell-cell adhesion molecule EpCAM associates with the tight junction protein claudin 7. Exp Cell Res 2005; 309:345-57.
35. .Le Naour F, Zöller M. EpCAM, tetraspanins and claudin-7. Front Bioscience 2008;13:5847-65.
36. .Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 2005;5:136-48.
37. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-11.
38. Kleiger G, Grothe R, Mallick P, Eisenberg D. GXXXG and AXXXA: common α-helical interaction motifs in proteins, particularly in extremophiles. Biochemistry 2002;41:5990-7.
39. Litvinov SV, Balzar M, Winter MJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 1997;139:1337-48.
40. Yovchev Ml, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 2007;47:636 -47.
41. Schneider D, Engelman DM. Motifs of two small residues can assist but are not sufficient to mediate transmembrane helix interactions. J Mol Biol 2004;343: 799 - 804.
42. Zöller M. Gastrointestinal tumors, metastasis and tetraspanins. Z Gastroenterol 2006;44:573-86.
43. Matter K, Balda MS. Epithelial tight junctions, gene expression and nucleo-junctional interplay. J Cell Sci 2007;120:1505-11.
44. Sears HJ, Atkinson B, Mattis J, et al. Phase~I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet 1982;1:762-5.
45. Riethmüller G, Schneider-Gadicke E, Schlimok G, et al.; German Cancer Aid 17-1A Study Group. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 1994;343:1177-83.
46. Schweizer C, Strauss G, Lindner M, Marme A, Deo YM, Moldenhauer G. Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAMxCD64 (HEA125xl97) bispecific antibody. Cancer Immunol Immunother 2002;51:621 -9.
47. Sebastian M, Passlick B, Friccius-Quecke H, et al. Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study. Cancer Immunol Immunother 2007; 56:1637-44.
48. Kirman 1, Whelan RL. Drug evaluation: adecatumumab, an engineered human anti-EpCAM antibody. Curr Opin Mol Ther 2007;9:190-6.
49. Stish BJ, Chen H, Shu Y, Panoskaltsis-Mortari A, Vallera DA. Increasing anti carcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv. Clin Cancer Res 2007;13:3058-67.
50. Zeidler R, Mysliwietz J, Csánady M, et al. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK. cells and induces direct phagocytosis of tumour cells. Br J Cancer 2000;83:261-6.
51. Osada M, Ito E, Fermin HA, et al. The Wnt signaling antagonist Kremenl is required for development of thymic architecture. Clin Dev Immunol 2006;13:299-319.
52. Nelson AJ, Dunn RJ, Peach R, Aruffo A, Farr AG. The murine homolog of human Ep-CAM, a homotypic adhesion molecule, is expressed by thymocytes and thymic epithelia] cells. Eur J Immunol 1996;26:401 -8.
53. Claas C, Herrmann K, Matzku S, Moller P, Zöller M. Developmentally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ 1996;7:663-78.
54. Guillemot JC, Naspetti M, Malergue F, Montcourrier P, Galland F, Naquet P. Ep-CAM fransfection in thymic epithelial cell lines triggers the formation of dynamic actin-rich protrusions involved in the organization of epithelial cell layers. Histochem Cell Biol 2001;116:371 -8.
55. Kallergi G, Mavroudis D, Georgoulias V, Stournaras C. Phosphorylation of FAK. P1-3K. and impaired actin organization in CK-positive micrometastatic breast cancer cells. Mol Med 2007;13:79-88.
56. Hedrick SM. T cell development: bottoms-up. Immunity 2002;16:619-22.
57. Matzku S, Komitowski D, Mildenberger M, Zöller M. Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 1983;3:109-23.
58. Cannon SC, Strittmatter SM. Functional expression of sodium channel mutations identified in families with periodic paralysis. Neuron 1993;10:317-26.
59. Matzku S, Wenzel A, Liu S, Zöller M. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 1989;49:1294-9.
60. Pape UF, Hofmann 1, Langbein L, et al. Claudins form homo- and heterooligomeric complexes in tight junctions in vivo. Cell Struct Funct 2004;29:1-139.